Bajaj Healthcare Ltd.

BAJAJHCARE

₹671.7

-5.15% (-36.5)

Market Cap

₹2,121 Cr.

P/E

0.00

About

Bajaj Healthcare Ltd mainly focuses on development, manufacturing and supply of Amino Acids, Nutritional Supplements and Active Pharmaceutical Ingredients (API) for Pharmaceutical, Nutraceuticals and … Read more

Bajaj Healthcare Ltd mainly focuses on development, manufacturing and supply of Amino Acids, N… Read more

Low

265

52W Range

High

745

Timeline

Key company specific updates

Company Timeline

Custom financial statementNew

Edit rows

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024

In Rs. Cr.	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Balance sheet
Net Block	130	128	127	128	162	208	270	366	253	240
Shareholders Funds	88.63	99.00	114	129	178	258	328	368	278	446
Profit & Loss
Operating Profit	30.05	30.84	39.43	42.92	48.28	136	119	111	76.33	—
Net Sales	200	207	290	325	410	657	680	646	473	—
Cash flow
Cash from Operating Activity	25.14	22.12	16.61	25.17	20.57	43.56	0.69	-22.19	92.29	76.44
Net Capex (est)	30.43	9.75	9.77	15.00	18.32	62.00	79.26	93.07	19.04	1.12
Ratios
ROCE (%)	17.48	17.28	22.19	21.73	20.79	37.07	25.68	20.66	16.82	—
ROE (%)	9.25	7.90	13.37	12.63	14.18	32.16	21.73	11.70	-30.10	—

Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Debt

Company might have issues servicing its debt
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

R&D as a % of Total Sales (%)

Bajaj Healthcare Ltd.

R&D as a % of Total Sales (%)
Source

Peer Comparison

Peer Name	Latest Price	PE	Market cap(Cr)	Prom Holding(%)	YoY Qtly Sales(%)	ROCE (%)	ROE (%)
Bajaj Healthcare	671.7	0.00	2,121	59.19	13.1	16.82	-30.1
SMS Pharmaceuticals	212.78	28.53	1,886	64.67	7.35	12.77	9.29
IOL Chem & Pharma	61.2	18.47	1,796	52.62	0.56	11.74	8.34
Solara Active Pharma	513.2	0.00	2,464	37.23	41.7	-17.43	-60.75
Morepen Laboratories	47.84	20.81	2,622	35.65	1.85	15.61	11.35
Themis Medicare	146.98	29.25	1,350	67.15	13.69	10.69	11.52
Aarti Drugs	340.3	20.32	3,101	55.38	-8.14	16.7	13.38
Hester Biosciences	1,253.9	34.25	1,067	53.73	-5.62	8.47	6.47

Corporate Actions

Consolidated BonusDividendSplit

DATE

DETAILS

2024, Sep 23

Dividend Dividend of Rs.1 per share

2023, Sep 22

Dividend Dividend of Rs.1 per share

2022, Sep 22

Dividend Dividend of Rs.1.5 per share

2021, Sep 28

Dividend Dividend of Rs.0.5 per share

2021, Sep 28

Dividend Dividend of Rs.0.5 per share

FAQs on Bajaj Healthcare Ltd. Business

What does Bajaj Healthcare do?

Bajaj Healthcare Ltd specializes in producing Amino Acids, Nutritional Supplements, and Active Pharmaceutical Ingredients for Pharmaceutical, Nutraceuticals, and Food industries, offering a wide range of products.

Who are the competitors of Bajaj Healthcare?

Bajaj Healthcare major competitors are SMS Pharmaceuticals, IOL Chem & Pharma, Solara Active Pharma, Morepen Laboratories, Themis Medicare, Aarti Drugs, Hester Biosciences.
Market Cap of Bajaj Healthcare is ₹2,121 Crs.
While the median market cap of its peers are ₹1,886 Crs.

Is Bajaj Healthcare financially stable compared to its competitors?

Bajaj Healthcare seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep	Jun Sep Dec	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation				Mar Jun		Mar Jun
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Bajaj Healthcare Ltd.

View the discussion on Valuepickr - ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Bajaj Healthcare Ltd.